Friday, February 26, 2021
wellness India Expo
Home Tags Biocon

Tag: Biocon

Mylan & Biocon announce first joint USFDA submission for biosimilar, Trastuzumab

Besides being an important milestone of Biocon and Mylan's joint global biosimilars program, the first biosimilar trastuzumab if approved by the top regulator.....

Syngene registers Rs 319 crore as revenue in Q2

Syngene International, Biocon’s contract research arm has registered a 22 per cent increase in revenue......

Biocon’s net profit jumps to Rs 146.7 cr in 2nd quarter...

With consolidated net profit of Rs 146.7 crore, the biotechnology giant, Biocon has shown good performance for the second quarter of financial year 2016-17....

Dr Kas Subramanian joins Syngene International

Having headed the R&D division at the Strand Life Sciences, Dr Kalyanasundaram Subramanian will now spearhead the bioinformatics initiative....

Biocon registers strong performance, profits up by 17%

Biocon in the first quarter of the financial year 2016-17, has reported the revenues of Rs 952 crore; net profit up by 17 percent at Rs 147 crore ....

India’s first siRNA drug to treat rare eye disease soon

The elderly patients afflicted by a rare eye disease, NAION (non-arteritic ischemic optic neuropathy) that leads...

Syngene delivers sustained growth in its Quarter 4 results

The company's revenue grows 31 percent to Rs 334 crore and EBITA is up by 23 percent to Rs 106 crore...

Biocon’s Insulin, Glargine gets green signal from Japanese regulatory agency

The product is a ready-to-use, prefilled disposable pen with 3 ml of 100IU Insulin Glargine..

European Union opens doors to Biocon’s first generic formulation for the...

India's top biotech company, Biocon has announced that it has received European approvals for its Rosuvastatin Calcium 5 mg, 10 mg, 20 mg and...

Bioscience sector must get its due in this budget says Biocon...

The global economy is expected to slow down further in 2016 pulled down by weakness in major emerging economies like China, Brazil and Russia....